Approvals/TGA/XOLAIR omalizumab (rch) 150 mg solution for injection pre-filled pen

Approved

STANDARD

XOLAIR omalizumab (rch) 150 mg solution for injection pre-filled pen

Approval Id: aedb4ff03637318d
Product Name: XOLAIR omalizumab (rch) 150 mg solution for injection pre-filled pen
Artg Id: 429511
Artg Name: XOLAIR omalizumab (rch) 150 mg solution for injection pre-filled pen
Sponsor: Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path: /organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date: 2024-09-04
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-CMI-05307-3
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2009-PI-00304-3

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

aedb4ff03637318d

Type

Standard